News

Scientists developed an anti-HIV protein called ZPAMt that can be delivered to affected areas using exosomes, nanosized parts of cells able to reach...

BioFluidica announced its plans to commercialize the market's first and only high throughput rare biomarker (circulating tumor cells, exosomes, and cell-free DNA) enrichment solution, the LiquidScan™ Automated...

Cells for Cells, a cell therapy developing company, just after the publication of new data of its OxiumTMEXO cell culture media for increased exosome production in Frontiers in Biotechnology and Bioengineering, hast published a new video explaining the technology. The ...

The structure and size of exosomes are not too different from the key player of the COVID-19...

A research group from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences reported a novel nanofluidic device for high-throughput preparation of exosome...

Scientists from the Max Planck Institute for Medical Research create synthetic exosomes with natural functionalities and present their therapeutic application...

MDimune Inc. and Vect-Horus are please to announce today the signing of a Research Collaboration Agreement. MDimune is a South Korean biotech company dedicated to the development of an innovative drug delivery platform called BioDrone® using...

Creative Biolabs updates the custom services of exosome targeting, covering exosome display and targeting exosome lentivirus vector construction, to escalate the development of nanoparticles for drug delivery and vaccine design. Exosomes are picking up steam among scientists because they can ...

In diseases such as hypertension, aging, atherosclerosis, diabetes and chronic kidney disease, arterial calcification and stiffening of the elastic...

The goal of the project is to understand mechanisms of biophysical modulation of mesenchymal stem cells (MSCs) to enhance the secretion of bioactive EVs...